Glenn Rockman
InvestorManaging Partner at Adjuvant Capital · Director at Iantech · Board director at Codagenix · Board director at VitriVax
New York, New York
Writes $100K – $5M checks · typically $1.5M
Find your path to Glenn
375 people in our graph share verified history with Glenn — schools, employers, funds. One of them is your warm intro.
Brad FloraunlockedGlenn: together at Princeton University (2000–2003)
×5Glenn: together at Princeton University
×2Glenn: together at Bill & Melinda Gates Foundation
×4Glenn: together at The Chinese University of Hong Kong
About
Glenn Rockman is Co-Founder and Partner at Adjuvant Capital, which he founded in 2018, with over 20 years of experience in venture capital and investment banking. He previously was a Managing Partner at the advisory firm managing the Global Health Investment Fund (GHIF) and an Executive Director in J.P. Morgan's Social Finance unit, where he spent more than a decade before focusing on life sciences investing. He holds an AB in public policy from the Princeton School of Public and International Affairs.
Contact· self-published, not guessed
Invests in
BiotechHealthtech
Director at Iantech
Intro paths
→
In turn, Glenn can intro founders to Iantech's investors below.
Iantech's investors · 3
Co-founders at Iantech
TI
Tsontcho IanchulevExecutive Officer, Director
Board director at Codagenix
Intro paths
→
In turn, Glenn can intro founders to Codagenix's investors below.
Codagenix's investors · 6
Co-founders at Codagenix
JR
John Robert ColemanExecutive Officer, Director
SM
Steffen MuellerCo-Founder, President & Chief Scientific Officer
Board director at VitriVax
Intro paths
→
In turn, Glenn can intro founders to VitriVax's investors below.
VitriVax's investors · 4
Co-founders at VitriVax
TR
Theodore RandolphDirector
Experience
- Adjuvant CapitalFounder and Managing Partnercurrent2018 — presentNew York
- Quantoom BiosciencesDirectorcurrent2025 — presentBrussels, Brussels Region, Belgium
- VitriVaxDirectorcurrent2020 — presentBoulder, Colorado, United States
- WaterEquityMember - Council of Directorscurrent2020 — present
- Codagenix, Inc.Directorcurrent2020 — presentFarmingdale, NY
- UNIVERCELLSDirector2018 — 2025Brussels Area, Belgium
- RIGHT FUND, Research Investment for Global Health Technology Fund FoundationDirector2018 — 2025Gwanak-gu, Seoul, Korea
- X-Vax Technology, Inc.Director2022 — 2023
- X-Vax Technology, Inc.Board Observer2019 — 2022
- InDevR, Inc.Director2019 — 2022Boulder, CO
- Global Health Investment CorporationSecretary-Treasurer2015 — 2021New York, New York, United States
- EuBiologics co.,LtdDirector2016 — 2021Seocho-gu, Seoul, Korea
- Themis Bioscience GmbHDirector2017 — 2020Vienna, Austria
- Global Health Investment FundCo-Managing Partner of Global Health Investment Fund's Investment Manager2014 — 2019New York, NY
- IanTECHDirector2017 — 2018Reno, Nevada Area
- Tribendimidine Finance CompanyDirector2016 — 2018
- Moxidectin for Onchocerciasis Company LimitedDirector2015 — 2018London, United Kingdom
- J.P. MorganExecutive Director, Social Finance2014New York, NY
- J.P. MorganVice President, Social Finance2012 — 2014Greater New York City Area
- J.P. MorganVice President, Higher Education / Non-Profit Investment Banking2007 — 2012Greater New York City Area
- Bill & Melinda Gates FoundationJ.P. Morgan Secondee2011Seattle, WA
Skills & more
Global HealthInfectious DiseasesLife SciencesImpact InvestingInvestmentsFinancial StructuringCapital MarketsInvestment BankingFinancial AnalysisEmerging MarketsNon-profitsFinancial Modeling
+12 more
Fixed IncomeDerivativesRisk ManagementFinancial MarketsFinanceStart-upsVenture CapitalPortfolio ManagementBiotechnologyBiopharmaceuticalsMedical DevicesAsset ManagementLanguages English
From Glenn's professional profile.
Investments
Board seats
CodagenixEuBiologicsIanTechMoxidectin for Onchocerciasis LimitedUnivercellsVitriVax
Sources: the firm's website · curated public sources.
Colleagues at Adjuvant Capital
Abrar Haque
Associate at Adjuvant Capital
Alexandra (Sandra) Glucksmann
Advisory Partner at Adjuvant Capital
Christian Mandl
Senior Advisor at Adjuvant Capital
Curt LaBelle
Venture Partner at Adjuvant Capital
Evelyn Yanatos
Director of Finance and Compliance at Adjuvant Capital
Gerard Cunningham
Operating Partner at Adjuvant Capital
Giulia Balconi
Associate at Adjuvant Capital
Jim Robinson
Senior Advisor at Adjuvant Capital
Network3
Jenny Yip
Managing Partner at Adjuvant Capital
Kabeer Aziz
Co-Founder and Partner at Adjuvant Capital
Mark Sullivan
Venture Partner at Adjuvant Capital
Investors connected to Glenn in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Glenn Rockman?
- Glenn Rockman is Co-Founder and Partner at Adjuvant Capital, which he founded in 2018, with over 20 years of experience in venture capital and investment banking. He previously was a Managing Partner at the advisory firm managing the Global Health Investment Fund (GHIF) and an Executive Director in J.P. Morgan's Social Finance unit, where he spent more than a decade before focusing on life sciences investing. He holds an AB in public policy from the Princeton School of Public and International Affairs.
- Where does Glenn Rockman work?
- Glenn Rockman is Managing Partner at Adjuvant Capital and Board director at Codagenix and Board director at VitriVax.
- What does Glenn Rockman invest in?
- Glenn Rockman invests in Biotech, Healthtech.
- What check size does Glenn Rockman write?
- Glenn Rockman typically writes checks of $100K – $5M.
- What boards does Glenn Rockman sit on?
- Glenn Rockman holds tracked board seats at Codagenix, EuBiologics, IanTech, Moxidectin for Onchocerciasis Limited, Univercells, VitriVax.
- What companies has Glenn Rockman invested in?
- Investments tracked here include Codagenix, Indevr, PATH, Themis, Themis Bioscience, VitriVax.
- Where did Glenn Rockman go to school?
- Glenn Rockman studied at Princeton University (BA, The Princeton School of Public and International Affairs); The Chinese University of Hong Kong (Study Abroad, Chinese Language (Mandarin)).
Same school
Also attended Princeton University998
Fabrice GrindaCo-founder & Managing Partner at FJ LabsRyan SheaCo-founder of Blockstack (Stacks)Dario AmodeiCo-founder & CEO of AnthropicFei-Fei LiCo-founder & CEO of World Labs; Sequoia Professor of Computer Science at StanfordCat WuInvestor at Index VenturesAndrewAdvisor at Clear Ventures
+ 992 more
Also attended The Chinese University of Hong Kong112
Sidd SrinivasaVenture Partner at Madrona Venture GroupBaxter BlackSenior Applied Data Scientist at Madrona Venture GroupMadeleine GoldbergInvestor at Lerer HippeauLily RaakaStrategist at Plum Alley InvestmentsMaría de Lera AuerspergInvestor at KfundBryson HearneAssociate at ResilienceVC
+ 106 more
